RT @evolutionarypsy: Probiotic and COVID twitter have now merged 🔥
RT @GMFHx: SARS-CoV-2 has been shown to impact gut microbiota and gut inflammation. New research reveals that receiving a 8-strain oral bac…
Conclusions: A specific bacterial formulation showed a significant ameliorating impact on the clinical conditions of patients positive for SARS-CoV-2 infection. These results also stress the importance of the gut-lung axis in controlling the COVID-19 disea
RT @GMFHx: SARS-CoV-2 has been shown to impact gut microbiota and gut inflammation. New research reveals that receiving a 8-strain oral bac…
RT @GMFHx: SARS-CoV-2 has been shown to impact gut microbiota and gut inflammation. New research reveals that receiving a 8-strain oral bac…
Probiotic and COVID twitter have now merged 🔥
RT @GMFHx: SARS-CoV-2 has been shown to impact gut microbiota and gut inflammation. New research reveals that receiving a 8-strain oral bac…
What is this about? @FatEmperor @gerdosi
RT @GMFHx: SARS-CoV-2 has been shown to impact gut microbiota and gut inflammation. New research reveals that receiving a 8-strain oral bac…
RT @GMFHx: SARS-CoV-2 has been shown to impact gut microbiota and gut inflammation. New research reveals that receiving a 8-strain oral bac…
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19 https://t.co/dZhZLoIQmn
SARS-CoV-2 has been shown to impact gut microbiota and gut inflammation. New research reveals that receiving a 8-strain oral bacteriotherapy led to a remission of diarrhea and a lower risk of respiratory failure in patients positive for COVID-19 https://t
RT @bykriscampbell: Published study on the use of a live biotherapeutic product (LBP) -- not yet approved as a drug -- to complement treatm…
RT @silypupilly: Amazing! #probiotics rule! https://t.co/sYUEnsH3gL
RT @bykriscampbell: Published study on the use of a live biotherapeutic product (LBP) -- not yet approved as a drug -- to complement treatm…
RT @bykriscampbell: Published study on the use of a live biotherapeutic product (LBP) -- not yet approved as a drug -- to complement treatm…
Sensationnel. Je passe en pharmacie ce soir.
RT @bykriscampbell: Published study on the use of a live biotherapeutic product (LBP) -- not yet approved as a drug -- to complement treatm…
Amazing! #probiotics rule!
RT @Prof_Braj_Singh: Frontiers | Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary The…
RT @bykriscampbell: Published study on the use of a live biotherapeutic product (LBP) -- not yet approved as a drug -- to complement treatm…
RT @bykriscampbell: Published study on the use of a live biotherapeutic product (LBP) -- not yet approved as a drug -- to complement treatm…
Frontiers | Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19 | Medicine https://t.co/R1QRgSQlx3
RT @bykriscampbell: Published study on the use of a live biotherapeutic product (LBP) -- not yet approved as a drug -- to complement treatm…
Published study on the use of a live biotherapeutic product (LBP) -- not yet approved as a drug -- to complement treatments for COVID-19. The group (n=28) receiving the 8-strain LBP showed remission of diarrhea & a lower risk of respiratory failure. ht